Molecular mechanisms of loss of β2-microglobulin expression in drug- resistant breast cancer sublines and its involvement in drug resistance

Biochemistry

Volumn 37, Issue 33, 1998, Pages 11679-11691

  Ogretmen, Besim ^a   McCauley, Mary D ^a   Safa, Ahmad R ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMSACRINE; BETA 2 MICROGLOBULIN; BETA ACTIN; COMPLEMENTARY DNA; CYCLOHEXIMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN; MESSENGER RNA; PACLITAXEL; VERAPAMIL; VINCRISTINE;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL STRAIN MCF 7; CELL SURVIVAL; GENE EXPRESSION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN PURIFICATION; PROTEIN SYNTHESIS;

BETA 2-MICROGLOBULIN; BREAST NEOPLASMS; CELL SURVIVAL; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; GENETIC VECTORS; HUMANS; PACLITAXEL; RNA, ANTISENSE; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; VINCRISTINE;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0032544223     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi980573c     Document Type: Article

References (46)

1. Drezen, J. M., Babinet, C., and Morello, D. (1993) J. Immunol. 150, 2805-2813.
2. Dixon, B., Stet, R. J. M., van Erp, S. H. M., and Pohajdak, B. (1993) Immunogenetics 38, 27-34.
3. D'Urso, C. M., Wang, Z., Cao, Y., Tatake, R., Zeff, R. A., and Ferrone, S. (1991) J. Clin. Invest. 87, 284-292.
4. York, A. I., and Rock, K. L. (1996) Annu. Rev. Immunol. 14, 369-396.
5. Kristoffersen, E. K., and Matre, R. (1996) Eur. J. Immunol. 26, 1668-1671.
6. Santos, M., Schilham, M. W., Rademakers, L. H., Marx, J. J., de Sousa, M., and Clevers, H. (1996) J. Exp. Med. 184, 1975-1985.
7. Rowley, D. R., Dang, T. D., McBride, L., Gerdes, M. J., Lu, B., and Larsen, M. (1995) Cancer Res. 55, 781-786.
8. Kaklamanis, L., Leek, R., Koukourakis, M., Gatter, K. C., and Harris, A. L. (1995) Cancer Res. 55, 5191-5194.
9. Restifo, N. P., Marincola, F. M., Kawakami, Y., Taubenberger, J., Yannelli, J. R., and Rosenberg, S. A. (1996) J. Natl. Cancer Inst. 88, 100-108.
10. Scaddan, P. B., and Dufresne, M. J. (1993) Invasion Metastasis 13, 301-313.
11. Vickers, P. J., Dufresne, M. J., and Cowan, K. H. (1989) Mol. Endocrinol. 3, 157-164.
12. Ogretmen, B., and Safa, A. R. (1996) Int. J. Cancer 67, 608-614.
13. Wosikowski, K., Regis, J. T., Robey, R. W., Alvarez, M., Buters, J. T. M., Gudas, J. M., and Bates, S. E. (1995) Cell Growth Differ. 6, 1395-1403.
14. Fleming, G. F., Amato, G. M., Agresti, M., and Safa, A. R. (1992) Cancer Chemother. Pharmacol. 29, 445-449.
15. Catapano, C. V., Carbone, G. M. R., Pisani, F., Qiu, J., and Fernandes, D. J. (1997) Biochemistry 36, 5739-5748.
16. Ogretmen, B., and Safa, A. R. (1997) Oncogene 14, 499-506.
17. Qiu, J., Catapano, C. V., and Fernandes, D. J. (1996) Biochemistry 35, 16354-16360.
18. Ogretmen, B., and Safa, A. R. (1995) BioTechniques 19, 374-376.
19. Ogretmen, B., Ratacjzak, H., Kats, A., Stark, B. C., and Gendel, S. M. (1993) BioTechniques 14, 932-935.
20. Noonan, K. E., Beck, C. Holzmayer, T. A., Chin, J. E., Wunder, J. S., Andrulis, I. L., Gazdar, A. F., Willmann, C. L., Griffith, B., Von Hoff, D. D., and Roninson, I. B. (1990) Proc. Natl. Acad. Sci. U.S.A. 87, 7160-7164.
21. Groudine, M., Peretz, M., and Weintraub, H. (1981) Mol. Cell. Biol. 1, 281-288.
22. Greenbere, M. E., and Ziff, E. B. (1984) Nature 311, 433-437.
23. Gant, T. W., Silverman, J. A., and Thorgeirsson, S. S. (1992) Nucleic Acids Res. 20, 2841-2846.
24. Muller, C., Goubin, F., Ferrandis, E., Cornil-Schwartz, I., Bailly, J. D., Bordier, C., Benard, J., Sikic, B. I., and Laurent, G. (1995) Mol. Pharmacol. 47, 51-56.
25. Marquardt, D., McCrone, S., and Center, M. S. (1990) Cancer Res. 50, 1426-1430.
26. Safa, A. R., Agresti, M., Bryk, D., and Tamai, I. (1994) Biochemistry 33, 256-265.
27. Cosgrove, D. E., and Cox, G. S. (1990) Arch. Biochem. Biophys. 280, 95-102.
28. Preval, C., and Mach, B. (1983) Immunogenetics 17, 133-140.
29. Rosa, F., Berissi, H., Weissenbach, J., Maroteaux, L., Fellous, M., and Revel, M. (1983) EMBO J. 2, 239-243.
30. Bernstein, P., and Ross, J. (1989) Mol. Cell. Biol. 9, 659-670.
31. Jackson, R. J., and Standard, N. (1990) Cell 62, 15-24.
32. Teh, M., and Hui, K. M. (1989) J. Immunogenet. 16, 397-405.
33. Gussow, D., Rein, R., Ginjaar, R., Hochstenbach, F., Seemann, G., Kottman, A., and Ploegh, H. L. (1987) J. Immunol. 139, 3132-3138.
34. Buszello, H., and Ackermann, R. (1992) Eur. Urol. 21, 70-74.
35. Fairchild, C. R., Moscow, J. A., O'Brien, E. E., and Cowan, K. H. (1990) Mol. Pharmacol. 37, 801-809.
36. Ohga, T., Koike, K., Ono, M., Makino, Y., Itagaki, Y., Tanimoto, M., Kuwlanesano, M., and Kohno, K. (1996) Cancer Res. 56, 4224-4228.
37. van der Krol, A. R., Mol, J. N. M., and Stuitje, A. R. (1988) BioTechniques 6, 958-976.
38. Giaccone, G., and Pinedo, H. M. (1996) In Multidrug Resistance in Cancer Cells (Gupta, S., and Tsuruo, T., Eds.) pp 473-492. John Wiley and Sons Ltd., New York.
39. Klein, T., Levin, I., Niska, A., Koren, R., Gal, R., Schacter, J., Kfir, B., Narinski, R., Warchaizer, S., and Klein, B. (1996) Eur. J. Immunogenet. 23, 417-423.
40. Klein, B., Levin, I., and Klein, T. (1996) Isr. J. Med. Sci. 32, 1238-1243.
41. Swan, F., Ordonez, N., Manning, J., Rodriguez, M. A., Redman, J., Velasquez, W., Hagemeister, F., McLaughlin, P., and Cabanillas, F. (1988) Blood 72, 258a.
42. Gorczyca, W., Gong, J., Ardelt, B., Traganos, F., & Darzynkiewicz, Z. (1993) Cancer Res. 53, 3186-3192.
43. Borner, C. (1996) J. Biol. Chem. 271, 12695-12698.
44. Karantza, V., Maroo, A., Fay, D., and Sedivy, J. M. (1993) Mol. Cell. Biol. 13, 6640-6652.
45. He, J., Choe, S., Walker, R., Di Marzio, P., Morgan, D. O., and Landau, N. R. (1995) J. Virol. 69, 6705-6711.
46. Sunday, M. E., Isselbacher, K. J., Gattoni-Celli, S., and Willett, C. G. (1989) Proc. Natl. Acad. Sci. U.S.A. 86, 4700-4704.